Antimalaria Drug Development & Pipeline

Artemisin traditionally cleave the peroxide bond by Fe(II) found in heme proteins, thus generating toxic oxygen radicals. Synthetic peroxides, thus are proving to be useful substitutes for artemisinin. The first-generation ozonide OZ277, known as arterolane [1], has been found to inhibit the growth of chloroquine-resistant (K1) and chloroquine sensitive (NF54) parasite strains. In 2012, the combination of arterolane maleate and piperaquine phosphate was released as a 3-day treatment in India [2]. The second-generation peroxide OZ439 (EC50 = 3.4– 4.0nM) is now undergoing Phase IIa studies. It features an 80aryl rather than an 80-alkyl group causing higher stability of the O– O bond towards Fe(II) increasing by 50-fold, presumably because of steric reasons. This in turn translates into a much longer half-life in both rats (t1/2 = 20 h for OZ439 vs. 1h for OZ277) and humans (t1/ 2 = 25–30h for OZ439) [3].

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-06-22

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.15406/JAPLR.2017.05.00136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence

  2017cited by this paper
• A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

  2015cited by this paper
• Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug

  2014cited by this paper
• Cell-based medicinal chemistry optimization of high throughput screening hits for orally active antimalarials. Part 2: hits from SoftFocus kinase and other libraries.

  2013cited by this paper
• QSAR study of amidino bis-benzimidazole derivatives as potent anti-malarial agents against Plasmodium falciparum

  2013cited by this paper
• UV-triggered Affinity Capture Identifies Interactions between the Plasmodium falciparum Multidrug Resistance Protein 1 (PfMDR1) and Antimalarial Agents in Live Parasitized Cells*

  2013cited by this paper
• Recent advances in malaria drug discovery.

  2013cited by this paper
• Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities.

  2012cited by this paper
• Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

  2012cited by this paper
• An efficient synthesis for a new class antimalarial agent, 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole

  2011cited by this paper
• Structure-activity relationships of 4-position diamine quinoline methanols as intermittent preventative treatment (IPT) against Plasmodium falciparum.

  2011cited by this paper
• Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

  2011influential reference
• Antiprotozoal compounds: state of the art and new developments.

  2011cited by this paper
• Fitness Trade-Offs in the Evolution of Dihydrofolate Reductase and Drug Resistance in Plasmodium falciparum

  2011cited by this paper
• Pharmacokinetics and Pharmacodynamics of Arterolane Maleate Following Multiple Oral Doses in Adult Patients With P. falciparum Malaria

  2011influential reference
• ML238: An Antimalarial Small Molecule of a Unique Structural Class

  2011cited by this paper
• Spiroindolones, a Potent Compound Class for the Treatment of Malaria

  2010cited by this paper
• Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins.

  2010cited by this paper
• The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).

  2010cited by this paper
• Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century.

  2009cited by this paper
• Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy

  2008cited by this paper
• Ferroquine: a new weapon in the fight against malaria

  2004cited by this paper
• Systematic review of amodiaquine treatment in uncomplicated malaria.

  1996cited by this paper

• Structure-based bioisosteric design, synthesis and biological evaluation of novel pyrimidines as antiplasmodial antifolate agents

  2022cites this paper
• Antiprotozoal agents: How have they changed over a decade?

  2021cites this paper
• Old and Recent Advances in Life Cycle, Pathogenesis, Diagnosis, Prevention, and Treatment of Malaria Including Perspectives in Ethiopia

  2020cites this paper